Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

The approval allows the company to market Imfinzi 120 mg/2.4 ml and 500 mg/10 ml in combination with gemcitabine and ...

AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...

In March, the company had received approval from the drug regulator to import and sell sodium zirconium cyclosilicate powder ...

Brigade Enterprises Ltd., Deepak Fertilizers and Petrochemicals Corp., Sun Pharmaceutical Industries Ltd. and AstraZeneca ...

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

GM Breweries, Hathway cable and datacom, HDFC life insurance, Just Dial, Bank of Maharashtra, ICICI Prudential Life Insurance ...

Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and increasingly capital-constrained environment.

Indian stock market on July 15 will track key corporate developments. HCLTech cut its FY26 margin guidance after weak Q1. Tata Technologies, Rallis India, and Tejas Networks reported mixed results.